Breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: all case studies will sign an informed consent, and also they should have the following conditions: 1) Have clinical stage 1 or 2 breast cancer that be approved by the physician 2) Not have previous history of cancer. 3) Not have serious non-malignant diseases such as cardiovascular, respiratory, renal, which may prevent definitive surgery . 4) They should be literate. 5) They should have language of Persian dialects. 6) Not have mental disorder and addictions which preventing decision-making process and giving informed consent for participating in this study. Exclusion criteria: In this study, if a patient has one of following characteristics, it will be excluded from the study: 1) If patient requires to intensive care. 2) If patient dies or migrate (so that access to the patient is not possible). 3) If patient participate in other studies
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Select therapeutic option. Timepoint: One to four days after intervention. Method of measurement: O'Connor questionnaire.;??Decision conflict. Timepoint: 1-4 days after intervention. Method of measurement: O'Connor traditional decisional conflict scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decision Regret. Timepoint: Eight weeks after intervention. Method of measurement: O'Connor Decision Regret Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
International Campus, Tehran University of Medical Sciences